Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4556 USD | -1.56% | -3.10% | -68.49% |
06/05 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
06/05 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-68.49% | 1.47Cr | |
-1.64% | 9.03TCr | |
-1.97% | 3.95TCr | |
-16.00% | 3.17TCr | |
+61.28% | 2.64TCr | |
-22.76% | 1.43TCr | |
-9.14% | 1.29TCr | |
-11.77% | 1.18TCr | |
-45.97% | 1.1TCr | |
+3.30% | 884.67Cr |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- Transcript : RedHill Biopharma Ltd., Q1 2021 Earnings Call, May 27, 2021